Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The investigator's laboratory is studying a skin disease known as psoriasis. The purpose of
this protocol is to study the action and the effects of Etanercept, on psoriasis. This
medication has been studied extensively and has been found to be effective and safe in the
treatment of psoriasis. The eligible patient will have 10% of his/her body surface area
involved with psoriasis vulgaris. This trial is a phase III study to help understand the
action of the drug etanercept, trade name Enbrel, for the adult patient with moderate to
severe plaque psoriasis and who is a candidate for internal medications.